ArticleFrontiers in oncology2023

An unresectable and metastatic intrahepatic cholangiocarcinoma with EML4-ALK rearrangement achieving partial response after first-line treatment with ensartinib: a case report.

Senmiao Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.